pregnenolone sulfate has been researched along with Behavior Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, D; Tang, W; Traynelis, SF; Yuan, H | 1 |
| Kamei, H; Nabeshima, T; Noda, Y; Yamada, K | 1 |
1 review(s) available for pregnenolone sulfate and Behavior Disorders
| Article | Year |
|---|---|
[Effects of sigma receptor ligands on psychiatric disorders].
Topics: Animals; Dehydroepiandrosterone; Disease Models, Animal; Humans; Learning Disabilities; Ligands; Memory Disorders; Mental Disorders; Pregnenolone; Progesterone; Receptors, sigma; Sigma-1 Receptor; Stress, Psychological; Substance-Related Disorders | 2003 |
1 other study(ies) available for pregnenolone sulfate and Behavior Disorders
| Article | Year |
|---|---|
Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
Topics: Allosteric Regulation; Animals; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Genetic Variation; Humans; Loss of Function Mutation; Mental Disorders; Nerve Tissue Proteins; Nervous System Diseases; Pregnenolone; Protein Structure, Secondary; Receptors, N-Methyl-D-Aspartate; Serine; Tobramycin; Xenopus laevis | 2020 |